Literature DB >> 12721907

Integrating measles and rubella surveillance: the experience in the Caribbean.

Beryl Irons1, Peter Carrasco, Victoria Morris-Glasgow, Carlos Castillo-Solórzano, Ciro A de Quadros.   

Abstract

In 1988, the Ministers of Health in the Caribbean Community resolved to eliminate cases of indigenous measles. Specific performance indicators were developed to regularly monitor the program. In 1998, selected countries in the Caribbean elected to accelerate rubella control. As a first step, surveillance for both measles and rubella was integrated, using the measles eradication system as a template. Between 1995 and 2000, 98%-99% of the surveillance sites reported weekly. During that time, the number of suspected measles and rubella cases that were disqualified by laboratory testing remained relatively constant at 94%-99%; however, the indicator for suspected cases investigated within 48 h improved from 89% in 1996 to 95% in 2000. This integrated surveillance system has thus proven to be as effective and efficient as the measles surveillance system alone. Limited changes were made to the initial measles system, and the transition was relatively smooth. The integrated system has been crucial to the control of rubella and for the maintenance of measles elimination in the Caribbean.

Entities:  

Mesh:

Year:  2003        PMID: 12721907     DOI: 10.1086/368031

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  2 in total

1.  Epidemiological impact of a nationwide measles immunization campaign in Viet Nam: a critical review.

Authors:  Hitoshi Murakami; Nguyen Van Cuong; Hong Van Tuan; Katsuyuki Tsukamoto; Do Si Hien
Journal:  Bull World Health Organ       Date:  2008-12       Impact factor: 9.408

Review 2.  Critical issues in implementing a national integrated all-vaccine preventable disease surveillance system.

Authors:  Terri B Hyde; Jon K Andrus; Vance J Dietz; Jon K Andrus; Terri B Hyde; Carla E Lee; Marc-Alain Widdowson; Jennifer R Verani; Cindy Friedman; Eduardo Azziz-Baumgartner; Adriana S Lopez; Aisha Jumaan; Vance J Dietz
Journal:  Vaccine       Date:  2013-07-02       Impact factor: 3.641

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.